Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 4, 2011, Pages 583-586

  Seillier, Alexandre ^a   Giuffrida, Andrea ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

Author keywords

AM251; Anandamide; Cannabinoid CB1 receptor; Elevated Plus Maze; Phencyclidine; URB597

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE; PHENCYCLIDINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; RAT;

AMIDOHYDROLASES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BENZAMIDES; CARBAMATES; ENZYME INHIBITORS; MALE; PHENCYCLIDINE; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

RATTUS;

EID: 79953698161     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.03.010     Document Type: Article

References (38)

1. D.C. Aguiar, A.L. Terzian, F.S. Guimaraes, and F.A. Moreira Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats Psychopharmacology (Berl) 205 2009 217 225
2. M.C. Audet, S. Goulet, and F.Y. Dore Enhanced anxiety follows withdrawal from subchronic exposure to phencyclidine in rats Behav Brain Res 176 2007 358 361 (Pubitemid 44880095)
3. A. Becker, and G. Grecksch Illumination has no effect on rats' behavior in the elevated plus-maze Physiol Behav 59 1996 1175 1177 (Pubitemid 26198198)
4. L.J. Bertoglio, and A.P. Carobrez Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions Behav Brain Res 132 2002 135 143 (Pubitemid 34462041)
5. T. Enomoto, Y. Noda, and T. Nabeshima Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis Methods Find Exp Clin Pharmacol 29 2007 291 301 (Pubitemid 47204052)
6. D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, and G. Tarzia Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation J Pharmacol Exp Ther 313 2005 352 358 (Pubitemid 40411361)
7. S.E. File, and P. Seth A review of 25 years of social interaction test Eur J Pharmacol 463 2003 35 53 (Pubitemid 36205071)
8. G. Griebel, J.L. Moreau, F. Jenck, J.R. Martin, and R. Misslin Some critical determinants of the behaviour of rats in the elevated plus-maze Behav Processes 29 1993 37 47
9. 1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine. Int J Neuropsychopharmacol 2011;14:17-28.
10. J. Haller, F. Matyas, K. Soproni, B. Varga, B. Barsy, and B. Nemeth Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission Eur J Neurosci 25 2007 2445 2456 (Pubitemid 46625912)
11. J. Haller, I. Barna, B. Barsvari, P.K. Gyimesi, S. Yasar, and L.V. Panlilio Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats Psychopharmacology (Berl) 204 2009 607 616
12. S.L. Handley, J.W. McBlane, M.A. Critchley, and K. Njung'e Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors Behav Brain Res 58 1993 203 210 (Pubitemid 24024059)
13. 1 receptors may modulate fear extinction Pharmacol Res 56 2007 367 381 (Pubitemid 350026395)
14. M.D. Lapiz-Bluhm, C.O. Bondi, J. Doyen, G.A. Rodriguez, T. Bedard-Arana, and D.A. Morilak Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats J Neuroendocrinol 20 2008 1115 1137
15. P.R. Lee, D.L. Brady, R.A. Shapiro, D.M. Dorsa, and J.I. Koenig Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin Neuropsychopharmacology 30 2005 1883 1894 (Pubitemid 41486413)
16. R. Marsch, E. Foeller, G. Rammes, M. Bunck, M. Kossl, and F. Holsboer Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice J Neurosci 27 2007 832 839 (Pubitemid 46174502)
17. G. Martinez, C. Ropero, A. Funes, E. Flores, C. Blotta, and A.I. Landa Effects of selective NMDA and non-NMDA blockade in the nucleus accumbens on the plus-maze test Physiol Behav 76 2002 219 224 (Pubitemid 34607230)
18. S.L. McLean, M.L. Woolley, and J.C. Neill Effects of subchronic phencyclidine on behaviour of female rats on the elevated plus maze and open field J Psychopharmacol 24 2010 787 790
19. 3 receptor null mice to excitotoxic or anxiogenic stimuli: possible involvement of the endocannabinoid and endovanilloid systems Neurobiol Dis 36 2009 70 80
20. V. Micale, L. Cristino, A. Tamburella, S. Petrosino, G.M. Leggio, and F. Drago Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels Neuropsychopharmacology 34 2009 593:606
21. A.M. Moise, S.A. Eisenstein, G. Astarita, D. Piomelli, and A.G. Hohmann An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters Psychopharmacology (Berl) 200 2008 333 346
22. 1 receptors Neuropharmacology 54 2008 141 150 (Pubitemid 350299416)
23. M.G. Morgese, T. Cassano, V. Cuomo, and A. Giuffrida Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors Exp Neurol 208 2007 110 119 (Pubitemid 47600153)
24. J.B. Murray Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research J Psychol 136 2002 319 327
25. N. Naderi, A. Haghparast, A. Saber-Tehrani, N. Rezaii, A.M. Alizadeh, and A. Khani Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice Pharmacol Biochem Behav 89 2008 64 75
26. P.S. Naidu, S.A. Varvel, K. Ahn, B.F. Cravatt, B.R. Martin, and A.H. Lichtman Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality Psychopharmacology (Berl) 192 2007 61 70 (Pubitemid 46673891)
27. 1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour Neuropharmacology 54 2008 151 160 (Pubitemid 350299412)
28. T. Rubino, N. Realini, C. Castiglioni, C. Guidali, D. Vigano, and E. Marras Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex Cereb Cortex 18 2008 1292 1301 (Pubitemid 351769783)
29. F. Sams-Dodd Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test Neurosci Biobehav Rev 23 1998 287 293 (Pubitemid 29011631)
30. C.J. Santos, C.A. Stern, and L.J. Bertoglio Attenuation of anxiety-related behaviour after antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus Behav Pharmacol 19 2008 357 360
31. M. Scherma, J. Medalie, W. Fratta, S.K. Vadivel, A. Makriyannis, and D. Piomelli The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition Neuropharmacology 54 2008 129 140
32. K. Schwabe, S. Klein, and M. Koch Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats Behav Brain Res 168 2006 150 160 (Pubitemid 43152063)
33. A. Seillier, and A. Giuffrida Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801 Behav Brain Res 204 2009 410 415
34. 1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats Int J Neuropsychopharmacol 13 2010 373 386
35. A.A. Shah, and D. Treit Excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests Brain Res 969 2003 183 194 (Pubitemid 36369626)
36. 1A receptors Behav Brain Res 191 2008 26 31
37. A.L. Terzian, D.C. Aguiar, F.S. Guimaraes, and F.A. Moreira Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray Eur Neuropsychopharmacol 19 2009 188 195
38. D. Vigano, C. Guidali, S. Petrosino, N. Realini, T. Rubino, and V. Di Marzo Involment of the enocannabinoid system in phencyclidine-induced cognitive modelling of schizophrenia Int J Neuropsychopharmacol 12 2009 599 614